XML 33 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES AND SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Common Shares
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings (Accumulated Deficit)
Balance at Dec. 31, 2020 $ 2,207,018   $ 20,765 $ 1,765,323 $ 33,516 $ 387,414
Balance, Shares at Dec. 31, 2020   3,787 166,123      
Net issuance of common stock under stock-based plans 64   $ 112 (48)    
Net issuance of common stock under stock-based plans (in shares)     893      
Stock-based compensation expense 35,915     35,915    
Repurchase of common stock $ (416,180)   $ (411)     (415,769)
Repurchase of common stock (in shares) 3,300   (3,288)      
Cash dividends $ (49,757)         (49,757)
Settlements of convertible notes 841,202   $ 897 840,305    
Settlement of convertible debt (in shares)     7,178      
Exercise of convertible notes hedge call options (842,925)   $ (897) (842,028)    
Exercise of convertible notes hedge call options (in shares)     (7,178)      
Convertible common shares 906     906    
Convertible common shares (in shares)   (906)        
Net income 790,549         790,549
Other comprehensive loss (29,299)       (29,299)  
Balance at Oct. 03, 2021 2,537,493   $ 20,466 1,800,373 4,217 712,437
Balance, Shares at Oct. 03, 2021   2,881 163,728      
Balance at Jul. 04, 2021 2,493,256   $ 20,680 1,772,302 15,322 684,952
Balance, Shares at Jul. 04, 2021   21,386 165,444      
Net issuance of common stock under stock-based plans (258)   $ 1 (259)    
Net issuance of common stock under stock-based plans (in shares)     8      
Stock-based compensation expense 10,042     10,042    
Repurchase of common stock (212,996)   $ (215)     (212,781)
Repurchase of common stock (in shares)     (1,724)      
Cash dividends (16,452)         (16,452)
Settlements of convertible notes 637,497   $ 699 636,798    
Settlement of convertible debt (in shares)     5,589      
Exercise of convertible notes hedge call options (637,714)   $ (699) (637,015)    
Exercise of convertible notes hedge call options (in shares)     (5,589)      
Convertible common shares 18,505     18,505    
Convertible common shares (in shares)   (18,505)        
Net income 256,718         256,718
Other comprehensive loss (11,105)       (11,105)  
Balance at Oct. 03, 2021 2,537,493   $ 20,466 1,800,373 4,217 712,437
Balance, Shares at Oct. 03, 2021   2,881 163,728      
Balance at Dec. 31, 2021 2,562,444   $ 20,281 1,811,545 (5,948) 736,566
Balance, Shares at Dec. 31, 2021   1,512 162,251      
Net issuance of common stock under stock-based plans (4,192)   $ 95 (4,287)    
Net issuance of common stock under stock-based plans (in shares)     754      
Stock-based compensation expense 39,056     39,056    
Repurchase of common stock $ (750,000)   $ (903)     (749,097)
Repurchase of common stock (in shares) 7,200   (7,223)      
Cash dividends $ (52,617)         (52,617)
Settlements of convertible notes (213)   $ 151 (364)    
Settlement of convertible debt (in shares)     1,211      
Exercise of convertible notes hedge call options 0   $ (151) 151    
Exercise of convertible notes hedge call options (in shares)     (1,211)      
Convertible common shares 1,512          
Convertible common shares (in shares)   (1,512)        
Cumulative-effect of change in accounting principle related to convertible debt (6,234)     (100,834)   94,600
Net income 543,200         543,200
Other comprehensive loss (78,831)       (78,831)  
Balance at Oct. 02, 2022 2,254,125   $ 19,473 1,746,779 (84,779) 572,652
Balance, Shares at Oct. 02, 2022   0 155,782      
Balance at Jul. 03, 2022 2,298,596   $ 19,735 1,721,586 (52,959) 610,234
Balance, Shares at Jul. 03, 2022   0 157,880      
Net issuance of common stock under stock-based plans 12,052   $ 21 12,031    
Net issuance of common stock under stock-based plans (in shares)     169      
Stock-based compensation expense 13,194     13,194    
Repurchase of common stock (204,201)   $ (283)     (203,918)
Repurchase of common stock (in shares)     (2,267)      
Cash dividends (17,149)         (17,149)
Settlements of convertible notes (32)   $ 26 (58)    
Settlement of convertible debt (in shares)     207      
Exercise of convertible notes hedge call options 0   $ (26) 26    
Exercise of convertible notes hedge call options (in shares)     (207)      
Net income 183,485         183,485
Other comprehensive loss (31,820)       (31,820)  
Balance at Oct. 02, 2022 $ 2,254,125   $ 19,473 $ 1,746,779 $ (84,779) $ 572,652
Balance, Shares at Oct. 02, 2022   0 155,782